123 related articles for article (PubMed ID: 10546879)
1. What dual protease inhibitor combination for salvage therapies?
Rodríguez-Rosado R; Soriano V; Barreiro P; Dona C; González-Lahoz J
AIDS; 1999 Oct; 13(15):2180-1. PubMed ID: 10546879
[No Abstract] [Full Text] [Related]
2. Protease inhibitor boosting is complex, requires thorough knowledge of interactions.
Monier P
HIV Clin; 2004; 16(3):1-3. PubMed ID: 15366104
[No Abstract] [Full Text] [Related]
3. Salvage therapy in HIV-positive patients with a previous therapeutic experience with protease inhibitors. Members of the Master Group.
Maggiolo F; Maserati R; Pan A; Castelli F; Suter F
AIDS; 1999 Aug; 13(12):1591-2. PubMed ID: 10465091
[No Abstract] [Full Text] [Related]
4. Salvage therapy for patients failing their current antiretroviral regimen.
Albrecht MA
AIDS Clin Rev; 2000-2001; ():139-91. PubMed ID: 10999220
[No Abstract] [Full Text] [Related]
5. Salvage therapy with ritonavir-saquinavir plus two nucleoside reverse transcriptase inhibitors in patients failing with amprenavir-zidovudine-lamivudine.
De Wit S; Cassano P; Hermans P; Kabeya K; Gerard M; O'Doherty E; Clumeck N
AIDS; 1999 May; 13(7):864-5. PubMed ID: 10357390
[No Abstract] [Full Text] [Related]
6. Delavirdine: a review of its use in HIV infection.
Scott LJ; Perry CM
Drugs; 2000 Dec; 60(6):1411-44. PubMed ID: 11152019
[TBL] [Abstract][Full Text] [Related]
7. . . . from the 3rd International Workshop on salvage therapy for HIV infection.
Res Initiat Treat Action; 2000 Jun; 6(2):25-8. PubMed ID: 11707875
[No Abstract] [Full Text] [Related]
8. Virologic response of nine therapy-experienced children receiving 64 weeks of nelfinavir salvage therapy.
Vavro CL; Zimmermann AM; McClernon DR; Kehne SL; Martel LA; Valentine ME; McKinney RE
Ann N Y Acad Sci; 2000 Nov; 918():381-5. PubMed ID: 11131731
[No Abstract] [Full Text] [Related]
9. A review of dual protease inhibitor therapy.
Gallant JE
Hopkins HIV Rep; 1998 May; 10(3):1, 4-5. PubMed ID: 11365490
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of abacavir plus efavirenz as a salvage regimen in HIV-infected individuals after 48 weeks.
Wasmuth JC; Herhaus C; Römer K; Salzberger B; Kaiser R; Schliefer K; Voigt E; Rockstroh JK
AIDS; 2002 May; 16(7):1077-8. PubMed ID: 11953478
[No Abstract] [Full Text] [Related]
11. After the drugs: what's next?
Schouten JT
Res Initiat Treat Action; 1998 Dec; 4(7):9-10. PubMed ID: 11366085
[TBL] [Abstract][Full Text] [Related]
12. Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort Study.
Lorenzi P; Opravil M; Hirschel B; Chave JP; Furrer HJ; Sax H; Perneger TV; Perrin L; Kaiser L; Yerly S
AIDS; 1999 Feb; 13(2):F17-21. PubMed ID: 10202819
[TBL] [Abstract][Full Text] [Related]
13. Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients. Swiss HIV Cohort Study.
Khanna N; Klimkait T; Schiffer V; Irigoyen J; Telenti A; Hirschel B; Battegay M
AIDS; 2000 May; 14(7):791-9. PubMed ID: 10839586
[TBL] [Abstract][Full Text] [Related]
14. Salvage therapy studies.
Proj Inf Perspect; 1998 Sep; (25):7. PubMed ID: 11365850
[TBL] [Abstract][Full Text] [Related]
15. Rescue me.
Simmons P
Res Initiat Treat Action; 1998 Aug; 4(5):10. PubMed ID: 11365705
[TBL] [Abstract][Full Text] [Related]
16. Rescue regimens: the value of PI boosting.
Segal-Maurer S; Schütz M
Posit Aware; 2001; 12(6):35-7. PubMed ID: 11785478
[No Abstract] [Full Text] [Related]
17. Rescue regimens: the value of protease-inhibitor boosting.
Segal-Maurer S; Schütz M
Body Posit; 2001 Sep; 14(9):11-3. PubMed ID: 11693112
[No Abstract] [Full Text] [Related]
18. Antiretroviral news.
Gallant JE
Hopkins HIV Rep; 1998 Sep; 10(5):1, 4-7, 11. PubMed ID: 11365773
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral therapies.
Owen WF
Clin Podiatr Med Surg; 1998 Apr; 15(2):227-39. PubMed ID: 9576051
[TBL] [Abstract][Full Text] [Related]
20. Salvage therapy: still more intuition than data.
Gilden D
GMHC Treat Issues; 1999 Jan; 13(1):6-12. PubMed ID: 11366112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
